Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
NCT06183684
Cardiovascular Diseases, Heart Diseases
Tucson, Arizona, United States
View Trial DetailsNCT Number: NCT06926959
This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.
Interested in participating?
Request Info18 year and older
All sexes
Observational
The First Affiliated Hospital of Sun Yat-sen Univerity, Guangzhou, Guangdong, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Through study completion, an average of 5 years
Death due to any cause after enrollment
Time frame: Through study completion, an average of 5 years
Death caused by cardiac causes
Time frame: Through study completion, an average of 5 years
Hospitalization with the primary reason for admission as acute decompensated HF and administration of intravenous or mechanical heart failure therapies.
Contact information is provided by the study sponsor or research team.
Sun Yat-sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06183684
Cardiovascular Diseases, Heart Diseases
Tucson, Arizona, United States
View Trial DetailsNCT07171060
Cardiovascular Diseases, Heart Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT04097145
Cardiovascular Diseases, Heart Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT04433065
Cardiovascular Diseases, Heart Diseases
Birmingham, Alabama, United States
View Trial Details